# Tyra Biosciences, Inc.: Form SCHEDULE 13D/A, filed Sep 17, 2026

- Company: [Tyra Biosciences, Inc.](/companies/tyra.md) (CIK 1863127)
- Form: SCHEDULE 13D/A
- Filed: 2026-09-17
- Accepted by EDGAR: Sep 17, 2026, 16:32 ET
- Period: not reported
- Accession: 0001346824-26-000237
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1863127/000134682426000237/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1863127/000134682426000237/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1863127/000134682426000237/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Sep 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001346824-26-000237. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.